Related Experiment Video
Updated: Sep 2, 2025

06:05
Operational and Intervention Effects of Targeted Tuina in Lumbar Intervertebral Disc Degeneration Model Rabbits
Published on: July 21, 2023
606
Targeting clock-controlled gene Nrf2 ameliorates inflammation-induced intervertebral disc degeneration
Pandi Peng1,2, Dong Wang1, Xiaolong Xu1
1Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, People's Republic of China.
Arthritis Research & Therapy
|August 3, 2022
Summary
Inflammation disrupts the intervertebral disc (IVD) clock, leading to degeneration. Activating NRF2, a clock-controlled gene, may prevent or reverse IVD.
Area of Science:
- Biomedical Science
- Chronobiology
- Musculoskeletal Research
Background:
- Intervertebral disc (IVD) homeostasis relies on a diurnal mechanical loading cycle.
- Disruption of the IVD circadian clock is linked to intervertebral disc degeneration (IDD).
- The role of inflammation in disturbing the IVD clock and inducing IDD remains unclear.
Purpose of the Study:
- To investigate if inflammation disrupts the IVD clock and induces IDD.
- To explore the mechanism by which a dampened IVD clock leads to IDD.
- To identify potential therapeutic targets for IDD.
Main Methods:
- Induced IDD using IL-1β in nucleus pulposus (NP) tissues and cells.
- Knocked down the core clock gene Bmal1 to disrupt the NP cell circadian clock.
- Assessed the expression of NRF2 and inflammatory markers.
- Utilized an organotypic tissue-explant model to evaluate NRF2 activation.
Main Results:
- Inflammation (IL-1β) dampened the IVD clock in human and rat NP tissues and cells.
- Bmal1 knockdown disrupted the NP cell circadian clock, causing cell dysfunction.
- Bmal1 knockdown reduced NRF2 expression, increasing inflammation, oxidative stress, and apoptosis.
- NRF2 activation mitigated NP cell dysfunction and tissue degeneration.
Conclusions:
- Inflammation disrupts the IVD clock, contributing to IDD.
- The Bmal1-NRF2 pathway is crucial in regulating NP cell function and IDD.
- Targeting NRF2 offers a potential therapeutic strategy for preventing and recovering from IDD.

